Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.

Neurology Today in 5

Neurology Today

SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens

MAR 21, 20244 MIN
Neurology Today in 5

SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens

MAR 21, 20244 MIN

Description

Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.